Krystal Biotech, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
KRYS Nasdaq 2836 www.krystalbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Krystal Biotech, Inc.

Why Is Krystal Biotech (KRYS) Down 3.5% Since Last Earnings Report? - Jun 5th, 2025 9:30 am
Exploring Three High Growth Tech Stocks In The US Market - Jun 5th, 2025 5:38 am
Krystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare Conference - Jun 3rd, 2025 6:00 am
Three Insider-Favored Growth Companies To Watch - Jun 2nd, 2025 11:35 am
Implied Volatility Surging for Krystal Biotech Stock Options - Jun 2nd, 2025 9:04 am
Krystal Biotech's (NASDAQ:KRYS) Solid Earnings Have Been Accounted For Conservatively - May 13th, 2025 5:04 am
Biotech Alert: Searches spiking for these stocks today - May 10th, 2025 9:55 am
Krystal Biotech, Inc. (KRYS): Among the Best Cancer Stocks to Invest in for Long-Term Gain - May 9th, 2025 8:30 am
Krystal Biotech to Present at BofA Securities 2025 Health Care Conference - May 7th, 2025 6:00 am
Krystal Biotech First Quarter 2025 Earnings: Misses Expectations - May 7th, 2025 4:18 am
Krystal Biotech Inc (KRYS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ... - May 7th, 2025 1:08 am
Krystal Biotech Q1 Earnings and Sales Miss Estimates, Stock Down - May 6th, 2025 11:37 am
Krystal Biotech, Inc. (KRYS) Misses Q1 Earnings and Revenue Estimates - May 6th, 2025 7:15 am
Krystal Biotech Announces First Quarter 2025 Financial and Operating Results - May 6th, 2025 6:00 am
Earnings Preview: Intellia Therapeutics, Inc. (NTLA) Q1 Earnings Expected to Decline - May 1st, 2025 8:01 am
Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: Should You Buy? - Apr 29th, 2025 8:01 am
Abeona cell therapy approved by FDA for rare skin condition - Apr 29th, 2025 4:24 am
Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa - Apr 28th, 2025 5:00 am
Krystal Biotech to Present at Upcoming Scientific Conferences - Apr 24th, 2025 6:00 am
Top Growth Companies With High Insider Ownership In April 2025 - Apr 21st, 2025 11:36 am